Antioxidant activity of tryptophan in rats under experimental endotoxic shock

Biomedicine and Pharmacotherapy

Volumn 64, Issue 1, 2010, Pages 77-81

  Bitzer Quintero, Oscar Kurt ^a   Dávalos Marín, Airam Jenny ^a,c   Ortiz, Genaro Gabriel ^a   Meza, Alma Rosa del Angel ^b   Torres Mendoza, Blanca Miriam ^b,d   Robles, Ramón Gaxiola ^a,e   Huerta, Veronica Chaparro ^a   Beas Zárate, Carlos ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^d Universidad del Valle de Atemajac   (Mexico)

^e Hospital General de Zona IMSS   (Mexico)

Author keywords

Cytokines; Lipopolysacharide; Melatonin; Tryptophan

Indexed keywords

4 HYDROXY ALKENAL; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MELATONIN; NITRIC OXIDE; NITRITE; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME MODIFICATION; FEMALE; LIPID PEROXIDATION; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; TISSUE LEVEL;

ANIMALS; ANIMALS, SUCKLING; ANTIOXIDANTS; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; LIPOPOLYSACCHARIDES; LUNG; MELATONIN; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC; TRYPTOPHAN;

EID: 73349127106     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.07.002     Document Type: Article

References (35)

1. Millward D.J. Metabolic demands for amino acids and the human dietary requirement. J Nutr 128 (1998) 256S-2576S
2. Beck M.A. Antioxidants and viral infection: host immune response and viral pathogenicity. J Am Coll Nutr 5 Suppl. (2001) 396S-397S
3. Feoli A.M., Siqueira I.R., Almeida L., Tramontina A.C., Vanzella C., Sbaraini S., et al. Effects of protein malnutrition on oxidative status in rat brain. Nutr 22 (2006) 166-175
4. Schiffrin J.E., Zekri-Ibnov N., Von der Weid T., and Blum S. Huesped: Interacción Microbiana y su Implicación en la Salud Humana. In: Marcos A. (Ed). Actualización en Nutrición (2003), Inmunidad e Infección. Médica Panamericana 89-92
5. Paganota S., Hirche F., and Eder K. Requirement of Tryptophan in relation to the supply of large neutral aminoacid in poultry. Science 82 (2003) 815-822
6. Miura H., Ozaki N., Sawada M., Isobe K., Ohta T., and Nagatsu T. A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11 3 (2008) 189-209
7. Miller C.L., Llenos I.C., Cwik M., Walkup J., and Weis S. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Neurochem Int 52 (2008) 1297-1303
8. Saleem D.H., Haider S., Khan M.M., Shamsi T., and Haleem D.J. Role of tryptophan in the pathogenesis of hepatic encephalopathy. J Park Med Assoc 58 (2008) 68-70
9. Ball H.J., Yuasa H.J., Austin C.J., Weiser S., and Hunt N.H. Indolamine 2,3 dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol 41 (2009) 467-471
10. Perez de la Cruz V., Konigsberg M., and Santamaria A. Kynurenine pathway and disease: an overview. CNS Neurol Disord Drug Targets 6 (2007) 398-410
11. Menard G., Turmel V., and Bissonnette E.Y. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 150 (2007) 340-348
12. Cloez-Tavarani I., and Changeux J.P. Nicotine and serotonin in immune regulation and inflammatory processes; a perspective. J Leukoc Biol 81 (2007) 599-606
13. De la Rocha N., Rottelli A., Aguilar C.E., and Pelzer L. Structural basis of the anti-inflammatory activity of melatonin. Arzneimittelforschung 57 (2007) 782-786
14. Kedizora-Kornatowska, Szewczyk-Golec K., Czuczejko J., Pawluk H., van Marke de Lumen k, Kozakiewicz M., et al. Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res 45 (2008) 312-317
15. Szczepanik M. Melatonin and its influence on immune system. J Physiol Pharmacol 58 Suppl. (2007) 115-124
16. Cardinalli D.P. Melatonin. Physiology and clinical applications. Vertex 18 (2007) 288-293
17. Mizok B.A. Metabolic derangements in sepsis and septic shock. Crit Care Clin 6 (2000) 319-336
18. Gao H., Evans T.W., and Finney S.J. Bench-to-beside review: Sepsis, severe sepsis and septic shock-does the nature of the infecting organism matter?. Crit Care 12 (2008) 213
19. Munford R.S. Severe sepsis and septic shock: The role of gram-negative bacteremia. Annu Rev Pathol Mech Dis 1 (2006) 467-496
20. Wong P.M.C., Chung S.W., and Sultzer B.M. Genes receptors signals and responses to lipopolysaccharide endotoxin. Scand J Immunol 51 (2000) 123-127
21. Herzum I., and Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 15 (2008) 581-587
22. Ebdrup L., Korg J., Granfeldt A., Larsen PØ, Vestergard C., Hokland M., et al. Leukocyte, plasma and organ-associated cytokine profiles in an animal model of acute inflammation. AMPIS 116 (2008) 352-360
23. Bitzer-Quintero O.K., Ortiz G.G., Ruiz-Rizo L., Torres-Mendoza B.M., Vazquez-Valls E., and Rodriguez-Perez M. Effects of melatonin on plasma levels of TNF-a, IL-1ß and IL-6 in mice after lipopolysaccharide administration. Biol Rhythms Res 36 (2005) 159-168
24. Kawaguchi R., Shimokawa T., Umehara N., Nunomura S., Tanaka T., Umehara N., et al. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signalling. J Reprod Immunol 77 (2008) 117-125
25. Cuffy M.C., Silverio A.M., Qin L., Wang Y., Eid R., Brandcher G., et al. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. J Immunol 179 (2007) 5246-5254
26. Bradford M.M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Annal Biochem 72 (1976) 248-254
27. Hissin P.J., and Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissue. Anal Biochem 74 (1976) 214-226
28. Cubero J., Valero V., Narciso D., Rivero M., Marchena J.M., Rodríguez A.B., et al. l-tryptophan administrated orally at night modifies the melatonin plasma levels, phagocytosis and oxidative metabolism in ringdo (Streptopelia roseogrisea) heterophils. Mol Cell Biochem 293 (2006) 79-85
29. Lissoni P., Tancini G., and Paolorossi F. Chemoneuroendocrine therapy of metastasic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study. J Pineal Res 26 (1999) 169-173
30. Feksa L.R., Latini A., Cielo Rech V., Feksa P.B., Duarte-Waltereith-Koch G., Arevalo-Amaral M.F., et al. Tryptophan administration induces oxidative stress in brain cortex of rats. Metab Brain Dis 23 (2008) 221-233
31. Samelson-Jones B.J., and Yeh S.R. Interactions between nitric oxide and indoleamine 2,3-dioxygenase. Biochemistry 45 (2006) 8527-8538
32. Kujundzié R.N., and Lowenthal J.W. The role of tryptophan metabolism in iNOS transcription and nitric oxide production by chicken macrophage cells upon treatment with interferon gamma. Immunol Lett 115 (2008) 153-159
33. Mulley W.R., and Nikolic-Paterson D.J. Indoleamine 2,3-dioxygenase in transplantation. Nephrology 13 (2008) 204-211
34. Kwidzinski E., and Bechamann I. IDO expression in the brain: a double-edged sword. J Mol Med 85 (2007) 1351-1359
35. Tu H., Rady P.L., Juelich T., Smith E.M., Tyring S.K., and Hughes T.K. Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation. Cell Mol Neurobiol 25 (2005) 673-680